Beyond CDMO

At NorthX Biologics, we are more than a Contract Development and Manufacturing Organization (CDMO), we are true partners in innovation.

Your innovation partner in advanced biologics

With deep scientific expertise and a collaborative mindset, we empower biopharma pioneers to transform visionary science into breakthrough therapies.

We don’t just support your project, we integrate with your team, align with your mission, and accelerate your path to the clinic and beyond. Together, we navigate the complexity of advanced biologics to bring life-changing treatments to patients.

Man in production clothes working on filling machine

Bioprocessing expertise

Our expertise within bioprocessing spans a variety of advanced modalities, including recombinant proteins, viral vaccines and cell therapy, we support your project from concept through to commercial manufacturing. With a flexible and agile mindset, we rapidly design and execute tailored programs to meet your development needs, from early-phase strategy to late-stage production.

Whether you’re developing recombinant proteins, viral vectors, plasmid DNA, mRNA, or cell and gene therapies, we deliver a full spectrum of GMP-compliant services, all under one roof. Our modular, phase-appropriate approach enables rapid scale-up and adaptability to evolving project needs.

Our complete CMC services

We can support your project from concept through to commercial manufacturing. Our speed and flexibility allow for rapid program design and execution to overcome development challenges.

Portrait of lab engineer
Lab staff portrait

The people of NorthX Biologics

At NorthX Biologics, we go beyond the traditional role of a CDMO. We are Beyond CDMO, and this commitment is exemplified by our exceptional team and innovative solutions. Our mission is to support your project with the expertise, dedication, and care that you deserve.

Discover how our cutting-edge technologies, experienced professionals, and comprehensive services can propel your project to new heights. Learn more about us, our people, and how we can help you achieve your goals.

Portrait of woman in lab coat

Why work with NorthX Biologics?

When working with a CDMO, it’s important to have a strong foundation to work from. Let us show you why you should work with us.

Small and experienced – Our dedicated team of 100+ professionals thrives on direct communication with subject matter experts and brings deep cross-functional experience to support your programs from early-stage to GMP manufacturing  Driven by science, empowered by innovation – As a Swedish Innovation Hub for Advanced Biologics, we are uniquely positioned to support cutting-edge projects with process development, scale-up, and technology transfer, as a one stop shop.

Responsive, reliable and ready – We deliver flexible, and phase-appropriate services across development and manufacturing, always aiming to ensure your timelines and quality standards are met.

NorthX Biologics headquarters

Come visit us

From our two facilities we offer support for progressing your advanced biologic. Our headquarter is located in Matfors, Sweden and our second site is located close to the center of Stockholm and in proximity to the Karolinska Institute and Karolinska Hospital.

Come visit us and see why we are Beyond CDMO.

Discover more

Placeholder image for NorthX Biologics secures significant growth investment from Signet Healthcare Partners

NorthX Biologics secures significant growth investment from Signet Healthcare Partners

NorthX Biologics, a leading Nordic biopharmaceutical Contract, Development, and Manufacturing Organization (CDMO), is pleased to announce a significant growth investment from Signet Healthcare Partners (Signet), a U.S.-based healthcare private equity ...

Placeholder image for NorthX Biologics appoints Johanna Magnusson as Chief Operating Officer

NorthX Biologics appoints Johanna Magnusson as Chief Operating Officer

Biopharmaceutical contract development and manufacturing organization (CDMO) NorthX Biologics is pleased to announce the appointment of Johanna Magnusson as Chief Operating Officer. With over two decades of leadership experience in ...

Placeholder image for NorthX Biologics receives CIR accreditation to support R&D collaboration with French biotech and pharmaceutical companies

NorthX Biologics receives CIR accreditation to support R&D collaboration with French biotech and pharmaceutical companies

NorthX Biologics, a leading biopharmaceutical CDMO, has been officially accredited by the French Ministry of Higher Education and Research for the Crédit d’Impôt Recherche (CIR) program for the years 2025-2026. ...

Let’s journey together

NorthX Biologics is dedicated to the journey of complex biologics. Let us know how we can help move your product forward.